USA • New York Stock Exchange • NYSE:ABBV • US00287Y1091
Taking everything into account, ABBV scores 5 out of 10 in our fundamental rating. ABBV was compared to 524 industry peers in the Biotechnology industry. ABBV has an average financial health and profitability rating. ABBV is cheap, but on the other hand it scores bad on growth. ABBV also has an excellent dividend rating.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.37 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.9 | ||
| Fwd PE | 15.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.67 | ||
| EV/EBITDA | 15.84 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.19% |
219.02
+1.91 (+0.88%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.9 | ||
| Fwd PE | 15.08 | ||
| P/S | 6.49 | ||
| P/FCF | 19.67 | ||
| P/OCF | 18.56 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.84 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.37 |
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.
ABBVIE INC (ABBV) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 21.9 and the Price/Book (PB) ratio is -146.51.
The Earnings per Share (EPS) of ABBVIE INC (ABBV) is expected to grow by 45.22% in the next year.